At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 20 enrolled
Drug / intervention
AZD2927 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi-Centre, Double-Blind, Randomised, Placebo-Controlled Phase II Study to Assess the Effects on Atrial and Ventricular Refractoriness of an Intravenous Infusion of AZD2927 in Patients Undergoing an Invasive Electrophysiological Procedure
In Brief
A Phase 2 clinical trial evaluating AZD2927 and Placebo for Arrhythmia. Completed, enrolled 20 participants across 5 sites in 2 countries.
Detailed Summary
Medical Products Agency
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArrhythmia
CountriesNorway, Sweden
Collaborators--
Timeline
Phase 2CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJul 2011
Enrollment StartSep 2011
Primary CompletionJan 2012
TodayJul 2026
First PostedJul 18, 2011
Enrollment StartSep 1, 2011
Primary CompletionJan 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 15.0 years ago
Interventions
AZD2927drug
A single dose of AZD2927 administered as an iv infusion
Placebodrug
A single dose of placebo administered as an iv infusion